Shionogi at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Shionogi brings 14 presentations to IDWeek 2026 in Washington, and exhibits at Booth 815, BS 10, BS 3, BS 4. Its program centres on cefiderocol against carbapenem-resistant gram-negative bacteria such as Pseudomonas, and on the COVID antiviral ensitrelvir. Distinctive work includes ensitrelvir for infected household contacts before symptoms appear and a cefiderocol and xeruborbactam combination in a urinary infection model.
| Organization | IDWeek 2026 Attendance |
|---|---|
Shionogi Osaka, Japan | |
Japanese pharmaceutical company focused on infectious diseases, whose U.S. subsidiary develops and sells anti-infective medicines. | Booth Exhibiting at Booth 815, BS 10, BS 3, BS 4 Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm Poster Thu Oct 22 12:15pm–1:30pm Activity of Cefiderocol Against Carbapenem-Resistant Pseudomonas aeruginosa Encountered In Each of the Different United States Census Bureau Divisions Poster Thu Oct 22 12:15pm–1:30pm Activity of Cefiderocol against Metallo-Beta-Lactamase Carrying Pseudomonas aeruginosa of the SENTRY Antimicrobial Surveillance Program (2020 – 2024) Poster Thu Oct 22 12:15pm–1:30pm Activity of cefiderocol against carbapenem nonsusceptible Gram-negative isolates from skin and soft tissue infections in US and European medical centers collected as part of the SENTRY antimicrobial surveillance program (2020-2024) Poster Thu Oct 22 12:15pm–1:30pm Bactericidal Activity of Cefiderocol/Xeruborbactam in a Murine Urinary Tract Infection Model Poster Thu Oct 22 12:15pm–1:30pm Clinical Outcomes After Cefiderocol Therapy for Pseudomonas spp. Infections: Results from a Systematic Literature Review Poster Thu Oct 22 12:15pm–1:30pm Outcomes of Cefiderocol Treatment in US Patients with Respiratory Tract Infections: Subgroup Analysis of the PROVE Observational Study Poster Thu Oct 22 12:15pm–1:30pm Systematic Literature Review of the Clinical Outcomes Associated with Cefiderocol Therapy for Stenotrophomonas maltophilia Infections Talk Fri Oct 23 12:25pm–12:30pm Cefiderocol Activity Across Highly Resistant Pseudomonas aeruginosa Ventilator-Associated Pneumonia Isolates: A Global Surveillance Study of SENTRY 2020-2024 Antimicrobials, resistance and stewardshipRespiratory infections and COVID-19 Talk Fri Oct 23 3:15pm–3:27pm Early Pre-Symptomatic Treatment with Ensitrelvir Among PCR-Positive, SARS‑CoV‑2–Exposed and Infected Household Contacts: SCORPIO‑PEP Subpopulation Analysis Antimicrobials, resistance and stewardshipRespiratory infections and COVID-19 Poster Sat Oct 24 12:15pm–1:30pm Brain Microstructural Disorganization as a Potential Mechanism of post-COVID-19 Condition and the Onset-suppressive Effects of Ensitrelvir Revealed by Advanced Diffusion MRI–based Translational Research Poster Sat Oct 24 12:15pm–1:30pm Cefiderocol Activity Across Highly Resistant Pseudomonas aeruginosa Ventilator-Associated Pneumonia Isolates: A Global Surveillance Study of SENTRY 2020-2024 Poster Sat Oct 24 12:15pm–1:30pm Ensitrelvir Suppresses Fatigue-like Symptoms Derived from SARS-CoV-2 Infection in Hamsters Poster Sat Oct 24 12:15pm–1:30pm Impact of Acute COVID-19 on Underlying Chronic Conditions: Systematic Literature Review Poster Sat Oct 24 12:15pm–1:30pm Reduction of Infectious SARS-CoV-2 and Viral Titer with Ensitrelvir: A Pooled Analysis of SCORPIO-SR and SCORPIO-HR Trials |
Instantly find 20 buyers from Shionogi
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction